Nektar Therapeutics
A biopharmaceutical company developing therapeutics for treating cancer, auto-immune disease, and chronic pain using their chemistry technology platform.
1
Funding Rounds
$25.0m
Money raised
Overview
A biopharmaceutical company developing therapeutics for treating cancer, auto-immune disease, and chronic pain using their chemistry technology platform.
-
Website:
- Business model: B2B
- Headquarters: San Francisco
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ho**** Ro*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Br*** L. Ko**** | - | - | - |
| Jo* Za* | - | - | - |
| Ji B. Th | - | - | - |
| Ma** A. Wi**** | - | - | |
| Je* Ru | - | - | |
| Ke*** Br* | - | - | - |
| Ma** Ta**** | - | - | |
| Ro**** Ba*** | - | - | - |
Funding series
Funding Series Analysis
The company Nektar Therapeutics has raised a total of $25m in funding over 1 rounds.
Key Insights:
- Nektar Therapeutics funding round, August 2013: $25m
Nektar Therapeutics funding round, August 2013
$25m
Industries
Nektar Therapeutics is active in the following industries: